Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Pediatr Dermatol ; 40(5): 869-872, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37495565

RESUMO

Isotretinoin is a systemic therapy approved for acne and has historically required lab monitoring in addition to adherence to the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) given the medication's teratogenic effects. The COVID-19 pandemic resulted in the expansion of telemedicine, acceptance of remote pregnancy tests, and relaxation of lab monitoring practices. A retrospective review of 142 pediatric patients was conducted, and multivariate linear regression was performed to examine differences in prescribing patterns pre-COVID and during COVID. Backward elimination identified gender and the interaction between acne severity and number of systemic treatments tried before isotretinoin as significant factors associated with increased number of visits to isotretinoin initiation, with females requiring more visits before starting isotretinoin at every acne severity level and even after accounting for systemic treatments previously tried. While the changes catalyzed by the pandemic may have improved visit-related burdens for patients and caregivers, female patients with acne continue to be delayed in receiving isotretinoin even when adjusting for acne severity and systemic treatments trialed, underscoring persistent gender disparities in prescribing practices for isotretinoin.


Assuntos
Acne Vulgar , COVID-19 , Fármacos Dermatológicos , Gravidez , Humanos , Feminino , Criança , Isotretinoína/efeitos adversos , Pandemias , Acne Vulgar/tratamento farmacológico , Estudos Retrospectivos , Fármacos Dermatológicos/uso terapêutico
2.
Dalton Trans ; 53(1): 196-205, 2023 Dec 19.
Artigo em Inglês | MEDLINE | ID: mdl-38019275

RESUMO

The process of water photo-electrolysis possesses the capability to generate sustainable and renewable hydrogen fuels, consequently addressing the challenge of the irregularity of solar energy. Thus, developing highly-efficient and low-cost electrocatalysts for the use in contemporary renewable energy devices is critical. Herein, we report the fabrication of a novel BaCeFex-yBixO6 nanocrystalline material through a one-step solvothermal route using a post-annealing process at 500 °C. The synthesized material was investigated for its light-induced electrochemical HER and OER activities in alkaline media and the results revealed that the as-prepared BaCeFex-yBixO6-500 °C exhibited an excellent OER activity with an overpotential of 100 mV to achieve a current density of 10 mA cm-2, thus outperforming the IrO2 electrocatalyst. Besides its excellent water oxidation performance, the catalyst also demonstrated an admirable HER activity comparable to that of the Pt/C catalyst, indicating that the higher temperature treatment plays a significant role in achieving the maximum performance of the developed electrocatalyst. This work provides insights into the enhancement of light-induced OER and HER activities of bismuth oxides for a wide range of catalytic applications.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA